---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-067005"
form_type: "8-K"
ticker: "TKNO"
cik: "0001850902"
company_name: "Alpha Teknova, Inc."
filed_at: "2025-05-08T23:59:59+00:00"
generated_at: "2026-05-22T05:30:45.125320+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Teknova Q1 revenue up 5% to $9.8M, net loss narrows to $4.6M, guidance reaffirmed

## Summary
- Q1 total revenue $9.8M (+5% YoY); Lab Essentials $8.1M (+12%), Clinical Solutions $1.2M (-32%).
- Net loss narrowed to $4.6M ($0.09/share) from $8.1M ($0.20/share) in Q1 2024.
- Adjusted EBITDA loss improved to $2.5M from $3.8M; free cash outflow decreased to $4.3M from $6.7M.
- Exclusive collaboration with Pluristyx to manufacture/distribute PluriFreeze cryopreservation system in US/Canada.
- Reaffirms FY2025 revenue guidance of $39-42M and free cash outflow under $12M.

## SEC filing metadata
- accession: 0000950170-25-067005
- form_type: 8-K
- ticker: TKNO
- cik: 0001850902
- company_name: Alpha Teknova, Inc.
- filed_at: 2025-05-08T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1850902/000095017025067005/0000950170-25-067005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1850902/000095017025067005/tkno-20250508.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-067005
- JSON: https://secwatch.observer/filing/0000950170-25-067005.json
- Plain text: https://secwatch.observer/filing/0000950170-25-067005.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.